Related Experiment Video
Updated: Jun 25, 2026

05:45
Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats
Published on: May 17, 2012
Streptozotocin-induced mechanical hypernociception is not dependent on hyperglycemia
Summary
Streptozotocin-induced painful diabetic neuropathy in rats causes mechanical hypernociception independent of high blood sugar. Localized streptozotocin also causes pain, suggesting direct nerve effects, not just hyperglycemia.
Area of Science:
- Neuroscience
- Pharmacology
- Endocrinology
Background:
- Diabetic neuropathy is a painful condition often modeled using streptozotocin (STZ) in rats.
- The role of hyperglycemia in STZ-induced pain remains incompletely understood.
Purpose of the Study:
- To investigate if STZ-induced mechanical hypernociception is solely dependent on hyperglycemia.
- To explore the effects of systemic and local STZ administration on pain.
Main Methods:
- Rats received varying doses of STZ intravenously or intraplantarly.
- Blood glucose levels, glucose tolerance, and weight gain were monitored.
- Mechanical hypernociception was assessed using standardized tests.
- Effects of insulin, systemic morphine, and local morphine were evaluated.
Main Results:
- Systemic STZ (40 mg/kg) increased blood glucose, but all STZ doses induced persistent mechanical hypernociception, irrespective of glycemic control.
- Insulin treatment did not prevent STZ-induced hypernociception.
- Systemic morphine, but not local morphine, inhibited STZ-induced hypernociception.
- Intraplantar STZ, even without hyperglycemia, induced local mechanical hypernociception responsive to both local and systemic morphine.
Conclusions:
- Systemic STZ-induced mechanical hypernociception in rats is independent of hyperglycemia.
- Intraplantar STZ induces mechanical hypernociception by sensitizing primary sensory neurons.
- These findings differentiate the mechanisms of STZ-induced pain depending on administration route.
Related Concept Videos
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...

